In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at ≤48 wk

By afschroeder • July 7, 2026

Hoo GWS; ACP Journal Club Editorial Team at McMaster University. In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at ≤48 wk. Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-26-02405-JC. Epub ahead of print. PMID: 42407070.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine, Veterans Administration

Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness

Lee CI, Lowry KP, Elmore JG. Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness. J Natl Cancer Inst. 2026 Jul 6:djag121.[...]

Nuclear mechanotransduction: tools for mechanical perturbation and chromatin characterization

Soto J, Origer N, Wu Y, Cardenas Benitez B, Massad R, Rahgoshay D, Lee A, Downing T, Li S. Nuclear mechanotransduction: tools for mechanical perturbation[...]

Cannabis Is Associated With Potentially Proatherogenic Inflammation in Youth

Kelesidis T, Fotooh Abadi L, Lama Tamang P, Hampilos K, Fong R, Sanchez J, Ruedisueli I, Gornbein J, Cooper ZD, Middlekauff HR. Cannabis Is Associated[...]